ThePrintAM: What did UK researchers find after tracking patients who stopped taking GLP-1 drugs?
ThePrint
00:00
Context: India’s obesity and diabetes burden
Neha provides Indian context: rising obesity, 135 million with diabetes, and semaglutide patent expiry implications.
Play episode from 04:09
Transcript
